AccScience Publishing / JCBP / Online First / DOI: 10.36922/jcbp.2601
Cite this article
116
Download
1870
Views
Journal Browser
Volume | Year
Issue
Search
News and Announcements
View All
MINI-REVIEW

Research progress in psychosomatic medicine in 2023: An overview

Yue Zhou1 Chenguang Jiang1 Wei Xu1 Zhuoliang Hou1 Yonggui Yuan1,2*
Show Less
1 Department of Psychosomatics and Psychiatry, Zhongda Hospital, School of Medicine, Southeast University, Nanjing, Jiangsu, China
2 Institute of Psychosomatics, ZhongDa Hospital, School of Medicine, Southeast University, Nanjing, Jiangsu, China
Submitted: 31 December 2023 | Accepted: 25 March 2024 | Published: 15 April 2024
© 2024 by the Author (s). This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution 4.0 International License ( https://creativecommons.org/licenses/by/4.0/ )
Abstract

Psychosomatic medicine focuses on exploring the interactions of biological, psychological, and social factors in regulating the balance between health and disease. Recent shifts in disease spectra and medical models have contributed to the heightened prevalence and burden of psychosomatic diseases, posing new challenges to the contemporary health-care system. Consequently, there has been an imperative drive toward intensified research in psychosomatic medicine. Neuroscience methodologies have been widely applied in the research of psychosomatic diseases, facilitating the exploration of underlying causal mechanisms of psychosomatic diseases and the examination of correlations between brain function, specific organ systems, and clinical manifestations. This article offers a review of the contemporary research developments in 2023 regarding the pathogenesis, diagnosis, treatment, and intervention strategies for psychosomatic diseases, approached from various systemic perspectives. Drawing upon these insights, it offers an outlook on the future of psychosomatic medicine, aiming to enhance the integration of body–mind to clinical practice for the management of psychosomatic diseases.

Keywords
Psychosomatic medicine
Psychosomatic diseases
Mechanism
Progress
Funding
None.
Conflict of interest
The authors declare that they have no competing interests.
References
  1. Fava GA, Cosci F, Sonino N. Current psychosomatic practice. Psychother Psychosom. 2017;86(1):13-30. doi: 10.1159/000448856

 

  1. Cosci F. The psychosomatic perspective. Psychother Psychosom. 2023;92(6):354-358. doi: 10.1159/000535262

 

  1. Yuan Y, Linden M. Inaugural editorial: A new journal and a new opportunity. JCBP. 2023;1(1):0370. doi: 10.36922/jcbp.0370

 

  1. Zhao B, Li T, Fan Z, et al. Heart-brain connections: Phenotypic and genetic insights from magnetic resonance images. Science. 2023;380(6648):abn6598. doi: 10.1126/science.abn6598

 

  1. Dill-McFarland KA, Altman MC, Esnault S, Jarjour NN, Busse WW, Rosenkranz MA. Molecular pathways underlying lung-brain axis signaling in asthma: Relevance for psychopathology and neuroinflammation. J Allergy Clin Immunol. 2024;153:111-121. doi: 10.1016/j.jaci.2023.07.025

 

  1. Hou R, Ye G, Cheng X, et al. The role of inflammation in anxiety and depression in the European U-BIOPRED asthma cohorts. Brain Behav Immun. 2023;111:249-258. doi: 10.1016/j.bbi.2023.04.011

 

  1. Gong W, Guo P, Li Y, et al. Role of the gut-brain axis in the shared genetic etiology between gastrointestinal tract diseases and psychiatric disorders: A genome-wide pleiotropic analysis. JAMA Psychiatry. 2023;80(4):360-370. doi: 10.1001/jamapsychiatry.2022.4974

 

  1. Dong WY, Zhu X, Tang HD, et al. Brain regulation of gastric dysfunction induced by stress. Nat Metab. 2023;5(9):1494-1505. doi: 10.1038/s42255-023-00866-z

 

  1. Vanuytsel T, Bercik P, Boeckxstaens G. Understanding neuroimmune interactions in disorders of gut-brain interaction: from functional to immune-mediated disorders. Gut. 2023;72(4):787-798. doi: 10.1136/gutjnl-2020-320633

 

  1. Liang S, Zhou Y, Yu C, et al. Chinese herbal medicine combined with cognitive–behavioural therapy for avoidant paruresis: A controlled trial. Gen Psychiatry. 2023;36(5):e101014. doi: 10.1136/gpsych-2023-101014

 

  1. Maina JG, Balkhiyarova Z, Nouwen A, et al. Bidirectional mendelian randomization and multiphenotype GWAS show causality and shared pathophysiology between depression and type 2 diabetes. Diabetes Care. 2023;46(9):1707-1714. doi: 10.2337/dc22-2373

 

  1. Lee J, Lazaridou A, Paschali M, et al. A randomized controlled neuroimaging trial of cognitive behavioral therapy for fibromyalgia pain. Arthritis Rheumatol. 2024;76(1):130-140. doi: 10.1002/art.42672

 

  1. Gordon EM, Chauvin RJ, Van AN, et al. A somato-cognitive action network alternates with effector regions in motor cortex. Nature. 2023;617(7960):351-359. doi: 10.1038/s41586-023-05964-2

 

  1. Doering S, Herpertz S, Hofmann T, et al. What kind of patients receive inpatient and day-hospital treatment in departments of psychosomatic medicine and psychotherapy in Germany? Psychother Psychosom. 2023;92(1):49-54. doi: 10.1159/000527881

 

  1. Frank P, Batty GD, Pentti J, et al. Association between depression and physical conditions requiring hospitalization. JAMA Psychiatry. 2023;80(7):690-699. doi: 10.1001/jamapsychiatry.2023.0777

 

  1. Yuan Y, Wu A, Jiang W. Psychosomatic medicine in China. Psychother Psychosom. 2015;84(1):59-60. doi: 10.1159/000365420

 

  1. Zhao R, Xin X, Yuan Y. Psychosomatic medicine in China: Past, present, and future. Chin J Clin (Electron Ed). 2022;16(8):703-711. doi: 10.3877/cma.j.issn.1674-0785.2022.08.001

 

  1. Yuan Y, Huang H, Zhang L, et al. Balancing psychotherapy and psychosomatic disorders. Pract Geriatr. 2017;31(10): 906-909. doi: 10.3969/j.issn.1003-9198.2017.10.003
Share
Back to top
Journal of Clinical and Basic Psychosomatics, Electronic ISSN: 2972-4414 Print ISSN: 3060-8562, Published by AccScience Publishing